C07D 281/14
[b, e]-condensed
C07D281/14 ([b, e]-condensed) appears on 20 US grants and 20 published applications in this corpus.
Search patents in C07D- Granted patents
- 20
- Published applications
- 20
- Assignees
- 20
- Inventors
- 74
- Latest grant
- 17 Oct 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 2 | 4 |
| 2007 | 1 | 0 |
| 2008 | 1 | 1 |
| 2009 | 1 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 1 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 2 |
| 2019 | 1 | 3 |
| 2020 | 0 | 1 |
| 2021 | 3 | 0 |
| 2022 | 0 | 2 |
| 2023 | 1 | 2 |
By publication year. Applications have been published since 2001.
Recent patents
- Carboxylic diarythiazepineamines as mixed mu- and delta-opioid receptor agonists17 Oct 2023US 11,787,772 B2The Trustees of Columbia University in the City of New York
- Hepatitis B core protein modulators27 Apr 2021US 10,987,360 B2Assembly Biosciences, Inc.
- Hepatitis B core protein allosteric modulators16 Mar 2021US 10,947,224 B2Assembly Biosciences, Inc.
- Selective bromodomain inhibition of fungal Bdf116 Feb 2021US 10,918,647 B2Cnrs
- Hepatitis B core protein allosteric modulators22 Jan 2019US 10,183,936 B2Assembly Biosciences, Inc.
- Carboxylic diarylthiazepineamines and uses thereof23 Nov 2023US 2023/0373940 A1
- Hepatitis b core protein allosteric modulators19 Jan 2023US 2023/0019129 A1Assembly Biosciences, Inc.
- Tricyclic dibenzothiazepine type compounds for use in the therapy of cdkl5 disorder25 Aug 2022US 2022/0265676 A1Healx Limited
- Hepatitis b core protein modulators27 Jan 2022US 2022/0023311 A1Assembly Biosciences, Inc.
- Carboxylic diarythiazepineamines as mixed mu-and delta-opioid receptor agonists12 Mar 2020US 2020/0079745 A1The Trustees of Columbia University in the City of New York
Most cited
By later US patents
- 3-alkoxy-2-aminopropyl heterocyclic amines and their use as cardiovascular agents7US 4,888,335 AMcNeilab, Inc. · 1989
- N-acylated lipophilic amino acid derivatives7US 6,864,250 B1Kaken Pharmaceutical Co., Ltd. · 2005
- Tricyclic heterocyclic sulfonamide and sulfonic ester derivatives6US 5,854,274 AEisai Co., Ltd. · 1998
- Tricyclic heterocyclic sulfonamide and sulfonic ester derivatives4US 5,846,969 AEisai Co., Ltd. · 1998
- Quetiapine salts and their polymorphs4US 8,101,597 B2Actavis Group Ptc Ehf · 2012